移植診斷市場規模、佔有率、成長分析、按技術、按產品和服務、按應用、按植入物類型、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球移植診斷市場規模為43億美元，從2023年的46.2億美元成長到2031年的82.4億美元，複合年成長率預計為7.5%。

在器官移植需求不斷成長、診斷技術進步以及導致器官衰竭的慢性疾病盛行率不斷上升的推動下，全球移植診斷市場正在經歷強勁成長。對準確、高效的移植相容性測試的迫切需求進一步支持了這一市場的擴張，這對於改善患者的治療結果和成功率至關重要。一個顯著的趨勢是將人工智慧 (AI) 和機器學習 (ML) 整合到移植診斷中，從而可以分析包括基因組和臨床資訊在內的大量資料集。這些先進技術不僅有助於識別配對模式和最佳化器官分配，還能顯著提高診斷準確性和效率，最終改善移植手術中的病患治療效果和資源利用率。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析

移植診斷市場規模：依技術及複合年成長率（2024-2031）

• 市場概況
• 分子檢測技術
  • 基於PCR的分子檢測
  • 即時PCR
  • 序列特異性引子PCR
  • 序列特異性寡核苷酸PCR
  • 其他基於 PCR 的分子檢測
• 基於定序的分子測定
  • 桑格序列
  • 次世代定序
  • 其他基於定序的分子測定
• 非分子檢測技術

移植診斷市場規模：依產品/服務及複合年成長率（2024-2031）

• 市場概況
• 試劑/耗材
• 裝置
• 軟體和服務

移植診斷市場規模：按應用和複合年成長率（2024-2031）

• 市場概況
• 診斷用途
  • 移植前診斷
  • 傳染病檢查
  • 組織相容性試驗
  • 血液分析
  • 移植後診斷
• 研究用途

移植診斷市場規模：依移植類型及複合年成長率（2024-2031）

• 市場概況
• 固態器官移植
  • 腎臟移植
  • 肝臟移植
  • 心臟移植
  • 肺移植
  • 胰臟移植
  • 其他器官移植
• 幹細胞移植
• 軟組織移植
• 骨髓移植

移植診斷市場規模：按最終用戶和複合年成長率（2024-2031）

• 市場概況
• 醫院及移植中心
• 研究/學術機構
• 獨立參考實驗室

移植診斷市場規模與複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Abbott Laboratories（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Omixon Ltd.（Estonia）
• Hologic, Inc.（USA）
• Immucor, Inc.（USA）
• CareDx, Inc.（USA）
• Qiagen NV（Netherlands）
• BioGenuix, Inc.（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Fujifilm Holdings Corporation（Japan）
• Eurofins Scientific SE（Luxembourg）
• Genomatica, Inc.（USA）
• Illumina, Inc.（USA）
• Oxford Nanopore Technologies plc（UK）
• Pacific Biosciences of California, Inc.（USA）
• NanoString Technologies, Inc.（USA）
• Fluidigm Corporation（USA）
• Agilent Technologies, Inc.（USA）

結論和建議

Global Transplant Diagnostics Market size was valued at USD 4.3 billion in 2022 and is poised to grow from USD 4.62 billion in 2023 to USD 8.24 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

The global transplant diagnostics market is experiencing robust growth, fueled by rising organ transplantation demands, advancements in diagnostic technologies, and increasing chronic disease prevalence leading to organ failure. This market expansion is further supported by a critical need for precise and efficient transplant compatibility testing, essential for enhancing patient outcomes and success rates. A notable trend is the integration of artificial intelligence (AI) and machine learning (ML) into transplant diagnostics, enabling the analysis of vast datasets, including genomic and clinical information. These advanced technologies not only help identify compatibility patterns and optimize organ allocation but also significantly enhance the accuracy and efficiency of diagnostics, ultimately improving patient outcomes and resource utilization in transplant procedures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplant Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplant Diagnostics Market Segmental Analysis

Global Transplant Diagnostics Market is segmented by technology, product & services, application, transplant type, end user and region. Based on technology, the market is segmented into molecular assay technologies, sequencing based molecular assays and non molecular assays technologies. Based on product, the market is segmented into reagents & consumables, instruments and software & services. Based on application, the market is segmented into diagnostic application and research applications. Based on transplant type, the market is segmented into solid organ transplantation, stem cell transplantation, soft tissue transplantation and bone marrow transplantation. Based on end user, the market is segmented into hospitals and transplant centers, research & academic institutes and independent reference laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transplant Diagnostics Market

The Global Transplant Diagnostics market is primarily driven by the rising demand for organ transplantation procedures, largely influenced by the increasing prevalence of chronic conditions like end-stage renal disease, heart failure, and liver cirrhosis. As more patients seek effective treatments to enhance their quality of life, the recognition of organ transplantation's benefits is becoming widespread among both patients and healthcare providers. This growing awareness necessitates precise and efficient compatibility testing between donors and recipients, thereby propelling the expansion of the transplant diagnostics sector. Enhanced diagnostic methods are critical in ensuring successful transplant outcomes, further stimulating market growth.

Restraints in the Global Transplant Diagnostics Market

The Global Transplant Diagnostics market faces significant challenges due to the critical shortage of organ donors. The overwhelming demand for organ transplants surpasses the supply of suitable organs, resulting in extensive waiting lists for patients. This situation not only heightens the risk of mortality and disease advancement during these waiting periods but also hampers the performance of transplant diagnostic procedures. Consequently, the limited organ availability constrains the market potential for diagnostic products and services. Furthermore, ethical dilemmas, legal regulations, and cultural obstacles surrounding organ donation in various regions exacerbate this shortage, further restricting growth opportunities within the transplant diagnostics sector.

Market Trends of the Global Transplant Diagnostics Market

A prominent trend in the global transplant diagnostics market is the rising integration of next-generation sequencing (NGS) technology, which is transforming the landscape of organ transplantation. NGS enables comprehensive genetic profiling of both donors and recipients, significantly enhancing the matching process through detailed analysis of the human leukocyte antigen (HLA) system and other critical genetic markers. This cutting-edge approach surpasses traditional methods by accommodating a broader spectrum of HLA alleles, unveiling rare variants, and enabling the simultaneous evaluation of multiple genetic indicators. As such, NGS not only streamlines the diagnostic workflow but also holds the potential to substantially improve transplant success rates and patient outcomes through optimized donor-recipient compatibility.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Transplant Diagnostics Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Molecular Assay Technologies
  • Pcr-Based Molecular Assays
  • Real-Time Pcr
  • Sequence-Specific Primer-Pcr
  • Sequence-Specific Oligonucleotide-Pcr
  • Other Pcr-Based Molecular Assays
• Sequencing Based Molecular Assays
  • Sanger Sequencing
  • Next Generation Sequencing
  • Other Sequencing Based Molecular Assays
• Non Molecular Assays Technologies

Global Transplant Diagnostics Market Size by Product & Service & CAGR (2024-2031)

• Market Overview
• Reagents & Consumables
• Instruments
• Software & Services

Global Transplant Diagnostics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Diagnostic Application
  • Pre-Transplantation Diagnostics
  • Infectious Disease Testing
  • Histocompatibility Testing
  • Blood Profiling
  • Post -Transplantation Diagnostics
• Research Applications

Global Transplant Diagnostics Market Size by Transplant Type & CAGR (2024-2031)

• Market Overview
• Solid Organ Transplantation
  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Pancreas Transplantation
  • Other Organs Transplantation
• Stem Cell Transplantation
• Soft Tissue Transplantation
• Bone Marrow Transplantation

Global Transplant Diagnostics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals and Transplant Centers
• Research & Academic Institutes
• Independent Reference Laboratories

Global Transplant Diagnostics Market Size & CAGR (2024-2031)

• North America (Technology, Product & Service, Application, Transplant Type, End User)
  • USA
  • Canada
• Europe (Technology, Product & Service, Application, Transplant Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product & Service, Application, Transplant Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product & Service, Application, Transplant Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product & Service, Application, Transplant Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omixon Ltd. (Estonia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareDx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenuix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatica, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations